143 related articles for article (PubMed ID: 34518949)
1. miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer.
Wang W; Zhang W; Wu J; Zhou Z; Ma J
Clin Exp Med; 2022 Aug; 22(3):385-392. PubMed ID: 34518949
[TBL] [Abstract][Full Text] [Related]
2. Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer.
Yao M; Wang S; Chen L; Wei B; Fu P
Clin Exp Med; 2022 May; 22(2):201-207. PubMed ID: 33826023
[TBL] [Abstract][Full Text] [Related]
3. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
Zhang J; Kong X; Shi Q; Zhao B
Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion.
Sheng Y; Hu R; Zhang Y; Luo W
Clin Exp Med; 2020 Aug; 20(3):417-425. PubMed ID: 32279128
[TBL] [Abstract][Full Text] [Related]
6. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
8. miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4.
Xiong B; Lei X; Zhang L; Fu J
Biomed Pharmacother; 2017 May; 89():1401-1408. PubMed ID: 28320108
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.
Bai X; Wang Q; Rui X; Li X; Wang X
Technol Cancer Res Treat; 2021; 20():1533033820985858. PubMed ID: 33416035
[TBL] [Abstract][Full Text] [Related]
11. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
12. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer.
Wu J; Zhou Z
Clin Breast Cancer; 2021 Aug; 21(4):e462-e470. PubMed ID: 33637448
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
Wang R; Li G; Zhuang G; Sun S; Song Z
Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163
[TBL] [Abstract][Full Text] [Related]
15. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
[TBL] [Abstract][Full Text] [Related]
16. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
Jin W; Han H; Liu D
Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
[TBL] [Abstract][Full Text] [Related]
17. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated expression of miR-582 predicts poor prognosis and facilitates melanoma progression by targeting FOXC1.
Chen F; Zhang D
Arch Dermatol Res; 2022 Oct; 314(8):759-766. PubMed ID: 34628519
[TBL] [Abstract][Full Text] [Related]
20. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
